Skip to main content
. 2010 Oct;45(5 Pt 1):1227–1250. doi: 10.1111/j.1475-6773.2010.01117.x

Table 1.

Summary Statistics for Newly Diagnosed RA Patients by Plan Generosity, 2000–2005

Average plan biologic OOP costs in top quartile under medical benefits No Yes No Yes

Average plan biologic OOP costs under medical benefits (mean/SD) 436 (535) 4,364 (1,911) 722 (626) 4,961 (2,451)

Average plan biologic OOP costs in top quartile under pharmacy benefits No No Yes Yes

Average plan biologic OOP costs under pharmacy benefits (mean/SD) 133 (92) 176 (108) 1,177 (767) 1,456 (1,127)

Number of plans in the group 104 28 28 16

Mean (SD)

Demographics
Age 64 (15) 59 (14) 52 (15) 70 (12)
Age 65 or older (%) 48 33 16 80
Male (%) 28 32 28 39
Socioeconomic status
Currently working (%) 27 35 74 12
Median HH income (U.S.$1,000) 41 (9) 45 (11) 44 (10) 46 (12)
Urban residence (%) 99 99 99 99
Household composition
One or more family members (in plan) (%) 61 71 79 77
Family size 1.87 (0.96) 2.08 1.04) 2.48 (1.23) 1.88 (0.68)
Comorbid conditions (RA patient) (%)
Asthma 5 5 3 4
Hypertension 35 26 18 34
Diabetes 12 10 8 11
Hyperlipidemia 12 10 6 14
Heart disease 21 13 8 21
Depression 7 7 10 3
Osteoarthritis 24 17 15 24
Number of person-years 13,194 3,302 549 2,297

HH, household; OOP, out of pocket; RA, rheumatoid arthritis; SD, standard deviation.